My CONACYT Receive email
updates Edit Profile

Welcome to the Institutional Repository CONACYT

Bienvenido al Repositorio Nacional de México

Este es el medio de Acceso Abierto que el CONACyT ha habilitado para la consulta y el depósito de los recursos de información científica, tecnológica y de innovación (RIACTIs). El Repositorio Nacional busca poner a disposición del público en general los recursos de información derivados de proyectos de investigación científica, tecnológica y la innovación para facilitar su consulta, uso y reúso.

Browsing by Title

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Showing results 7662 to 7681 of 7832
< previous next >

Issue DateTitlePublication Type/ Resource TypeAuthor(s)Submit Date
6-Jan-2022Vaccinating children against COVID-19: commentary and mathematical modellingPreimpresoMichael Hawkes; Michael F Good7-Jan-2022
13-Jan-2020Vaccination in a two-group epidemic modelPreimpresoSebastian Anita; Malay Banerjee; Vitaly Volpert; Samiran Ghosh15-Jan-2021
10-Feb-2022Vaccination nudgesPreimpresoCarl Bonander; Mats Ekman; Niklas Jakobsson11-Feb-2022
2020Vaccine designers take first shots at COVID-19ArtículoCohen Jon.-
8-May-2023Vaccine effectiveness of BNT162b2 mRNA Covid-19 Vaccine in Children below 5 Years in German Primary CarePreimpresoChristoph Strumann; Otavio Ranzani; Jeanne Moor; Reinhard Berner; Nicole Toepfner; Cho-Ming Chao; Matthias Moor11-May-2023
30-Nov-2022Vaccine hesitancy, reactogenicity and immunogenicity of BNT162b2 and CoronaVac in pediatric patients with neuromuscular diseasesPreimpresoMichael Yu Kwan Leung; Sophelia Chan; Amy Suen; Samuel Mo Sheung Cheng; Daniel Leung; Sau Man Chan; Hing Sang Wilfred Wong; Joseph Sriyal Malik Peiris; Yu Lung Lau; Jaime S Rosa Duque3-May-2023
2020VACCINES FOR COVID-19: PERSPECTIVES, PROSPECTS, AND CHALLENGES BASED ON CANDIDATE SARS, MERS, AND ANIMAL CORONAVIRUS VACCINESArtículoSaif Linda J..-
15-Dec-2021Vaccines provide disproportional protection to the increased hospitalisation risk posed by the Delta variant of SARS-CoV2: a meta-analysisPreimpresoMirre Simons17-Dec-2021
17-Jun-2021VAERS data reveals no increased risk of neuroautoimmune adverse events from COVID-19 vaccinesPreimpresoChris von Csefalvay29-Dec-2021
15-Jan-2022Validation of a clinical and genetic model for predicting severe COVID-19PreimpresoGillian Dite; Nicholas Murphy; Erika Spaeth; Richard Allman17-Jan-2022
2020Validation of a Lysis Buffer Containing 4 M Guanidinium Thiocyanate (GITC)/ Triton X-100 for Extraction of SARS-CoV-2 RNA for COVID-19 Testing: Comparison of Formulated Lysis Buffers Containing 4 to 6 M GITC, Roche External Lysis Buffer and Qiagen RTL Lysis BufferArtículoScallan Martina F..; Dempsey Catherine.; MacSharry John.; O’Callaghan Isabelle.; O’Connor Paula M..; Horgan Conor P..; Durack Edel.; Cotter Paul D..; Hudson Sarah.; Moynihan Humphrey A..; Lucey Brigid.-
2020Validation of reported risk factors for disease classification and prognosis in COVID-19: a descriptive and retrospective studyArtículoTan Li.; Kang Xia.; Ji Xinran.; Wang Qi.; li Yongsheng.; Wang Qiongshu.; Miao Hongming.-
17-Feb-2022Validation of the RT-LAMP assay in a large cohort of nasopharyngeal swab samples shows that it is a useful screening method for detecting SARS-CoV-2 and its VOC variantsPreimpresoMIREYA CISNEROS VILLANUEVA; SUGELA SUSANA BLANCAS ZUGARAZO; ALBERTO CEDRO TANDA; MAGDALENA RIOS ROMERO; Eduardo Hurtado Córdova; Oscar Almaraz Rojas; DIANA RAQUEL ORTIZ SORIANO; VICTOR ALVAREZ HERNANDEZ; IVONNE ARRIAGA GUZMÁN; LAURA TOLENTINO GARCIA; ANTONIA SANCHEZ VIZCARRA; LAURA FATIMA LOZADA RODRIGUEZ; IRLANDA PERALTA ARRIETA; José Enrique Pérez Aquino; MARCO ALONSO ANDONEGUI ELGUERA; MARIANA CENDEJAS OROZCO; ALFREDO MENDOZA VARGAS; JUAN PABLO REYES GRAJEDA; ABRAHAM CAMPOS ROMERO; Jonathan Alcántar Fernández; José L. Moreno Camacho; JORGE RODRIGUEZ GALLEGOS; MARCO ESPARZA-LUNA RUIZ; JESUS ORTIZ RAMIREZ; MARIANA BENITEZ GONZALEZ; LAURA URIBE FIGUEROA; Ofelia Angulo; ROSAURA RUIZ GUTIERREZ; LUIS ALONSO HERRERA MONTALVO; ALFREDO HIDALGO MIRANDA18-Feb-2022
2020Validity of Wrist and Forehead Temperature in Temperature Screening in the General Population During the Outbreak of 2019 Novel Coronavirus: a prospective real-world studyArtículoGe Chen.; Jiarong Xie.; Guangli Dai.; Peijun Zheng.; Xiaqing Hu.; Hongpeng Lu.; Lei Xu.; Xueqin Chen.; Xiaomin Chen.-
2020Vapor H2O2 sterilization as a decontamination method for the reuse of N95 respirators in the COVID-19 emergencyArtículoEbru Oral.; Keith K Wannomae.; Rachel L Connolly.; Joseph A Gardecki.; Hui Min Leung.; Orhun K Muratoglu.; Anthony Griffiths.; Anna N Honko.; Laura E Avena.; Lindsay GA McKay.; Nick Flynn.; Nadia Storm.; Sierra N Downs.; Ralph Jones.; Brandon Emmal.-
2020Variable epitope library-based COVID-19 vaccine for current and future related epidemicsArtículoKaren Manoutcharian.; Jesus Guzman Valle.; Josue Odales.-
2020Variable Macro X Domain of SARS-CoV-2 Retains the Ability to Bind ADP-riboseArtículoDavid Frick.; Rajdeep S Virdi.; Nemanja Vuksanovic.; Narayan Dahal.; Nicholas R Silvaggi.-
2020Variable pool testing for infection spread estimationArtículoItsik Bergel.-
12-May-2020Variation among states in reducing coronavirus spread: impact of stay-at-home ordersPreimpresoR Condit26-Jan-2024
12-May-2020Variation among states in reducing coronavirus spread: impact of stay-at-home ordersPreimpresoR Condit28-Feb-2024
Showing results 7662 to 7681 of 7832
< previous next >